Recent

% | $
Quotes you view appear here for quick access.

Oclaro, Inc. Message Board

mgm2020 298 posts  |  Last Activity: Jun 27, 2016 3:25 PM Member since: Mar 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • to much higher levels. The volume and price spike of last week was an indication that there is money looking to come in----and it will. Anyone that was smart enough to buy the last time the stock was down at this level had a great trade opportunity, and this time the stock is likely to climb and continue higher as the first data from 2125, as well as the higher dose cohorts of 8400 inch closer and closer. We have AACR and ASH again later this year and Idera will likely be presenting at one or both since Bob said that they are looking to present at a major conference "in the fall".

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jun 23, 2016 3:03 PM Flag

    To quote a famous Hall-of-Famer, "The waiting is the hardest part". That's the Rock and Roll Hall of Fame, of course. Presenting the first sets of data at a prominent conference in the fall will have a very beneficial effect on the stock. Immunotherapy is all the rave right now, and will be for a long time. To have a compound with virtually no side effects that can boost the effects of powerful checkpoint inhibitors by 30, 40, 50% or more will be revolutionary in the battle against cancer.

    Sentiment: Strong Buy

  • Reply to

    Strong SELL

    by josephanastasiw Jun 21, 2016 11:10 AM
    mgm2020 mgm2020 Jun 21, 2016 5:02 PM Flag

    What does---pray tell? I think I would call 160 MILLION people that were NOT covered by insurance for PCM but now have coverage for it, and test results in fairly large trials showing the same---or BETTER---accuracy as tissue biopsy or blood draw with a simple--SELF-ADMINISTERABLE URINE TEST----quite remarkable at least, if not "legs". At $4.50/share with nearly ALL of the analysts pegging this company as at least a $300 million MC company less than a year ago and a very likely buyout candidate-----TROV is at least a speculative BUY. And any positive news vaults the stock price up a few dollars.

    Sentiment: Strong Buy

  • Reply to

    What’s new in Vin Milano’s PR today

    by amano_7 Jun 21, 2016 3:49 PM
    mgm2020 mgm2020 Jun 21, 2016 4:56 PM Flag

    Glaxo is looking for a new partner in other conditions after scuttling the continuation of their deal with IONS due to potential complications from their inferior 2nd generation science. The greater their interest, the more likely it is that they will throw more money in Idera's direction-----or make an offer for the company and all of it's research and IP. I am not leaning in that direction, but I do think that MANY more partnerships will be coming Idera's way. I also see the price of the stock getting back to much more normal levels within the next few months as we approach the release of new critical data.

    Sentiment: Strong Buy

  • 20% from the high of just over a week ago??? AND------Nuplazid is the ONLY DRUG approved for PDP with a price tag set at $23,000 for a year's supply(before insurance discounts and/or promotions)!! EVERYONE should be buying aggressively here! This is a golden opportunity to add or enter when the price was not expected to come back to this level. The buyout----WHEN(not if) it does come out of the blue, will be for at least $60/share and likely higher. To be a trader in this stock right now is just ridiculous, and is it really worth the risk for $1 or $2? The buyout will probably NOT be preceded by any "rumors" when it does occur and the stock price will just shoot up to, or open at the expected buyout price------unless there is a bidding war, which is also likely. Good luck trading, but I hope you have stainless steel cajones!

    Sentiment: Strong Buy

  • what happens to IDRA stock when it is shown that IMO-2125 increases the effectiveness of Keytruda(and likely many other checkpoint inhibitors) by 25, 35, 50% OR MORE-----first in melanoma, and then expanding into many other cancers. Keytruda has already been designated a breakthrough drug in melanoma, but that is just with a 40% success rate, so there is a LOT of room for improvement. The combination of 2125/Keytruda, or 2125/Yervoy. or 2125/Opdivo could see success rates never before imagined in some of the most difficult, tenacious, and deadly forms of cancer. The safety and tolerance of 2125 is already documented. It could be headed for the "fast track". And that is just one of Idera's many compounds headed for enormous success.

    Sentiment: Strong Buy

  • Reply to

    IDRA Short Volume Ratio enormous today

    by pursewarden06612 Jun 16, 2016 4:34 PM
    mgm2020 mgm2020 Jun 16, 2016 6:50 PM Flag

    So----do they just keep shorting? The stock IS only $1.56 and has very limited downside while it could spike MUCH higher in the near term. And-----in order for those shorts to be worth anything, they have to cover and buy those shares. Today was a nice positive.

    Sentiment: Strong Buy

  • The real long-term longs, of course, are hoping that the rally continues and the company and 8400 and 2125 pan out into what has been predicted---- by preclinical data, corroborating data(from companies like PCYC with their CPI/TLR combo data), and results already seen with 8400 at low doses. This stock could jump $1.00 in a few days under the right circumstances------and I think that's what we are headed for in the near future. And then there is the most advanced 3GA platform ever seen......

    Sentiment: Strong Buy

  • Reply to

    IDRA Short Volume Ratio enormous today

    by pursewarden06612 Jun 16, 2016 4:34 PM
    mgm2020 mgm2020 Jun 16, 2016 5:48 PM Flag

    That is very likely. I agree that the share price will certainly spring back to life later in the year with the first set of data available(hopefully at a major conference) from 2125/melanoma, as well as the higher dose cohorts of 8400 in WM and DLBCL. BUT-----I do think there was something underlying the price spike today on very high volume. We had Milano buy stock at $1.97 a few months ago, and 2 other insiders recently made purchases in this price range. I think some news has escaped, and we will hear something very soon.

    Sentiment: Strong Buy

  • Reply to

    MGM all excited now. LOL

    by jk4763 Jun 16, 2016 1:33 PM
    mgm2020 mgm2020 Jun 16, 2016 5:41 PM Flag

    There has to be something to get excited about-----and a spike to $1.72 is a pretty nice reason on 200,000 shares in one minute. Shame nothing excites you except for a "great trade" on 100 shares and a 50 cent gain. But lack of emotion is a characteristic of Asberger's. But I've been considering that-----another characteristic is usually intelligence-----but you clearly demonstrate none of that, so you are just a run-of-the-mill troll with autism.

    Sentiment: Strong Buy

  • Reply to

    The no reason rally

    by oilup12345 Jun 16, 2016 2:54 PM
    mgm2020 mgm2020 Jun 16, 2016 5:38 PM Flag

    Yes----world class CEO's like Vince Milano and a world renown CMO like Joanna Horobin as well as all of the doctors at MD Anderson just had the wool pulled right over their eyes! WHY ARE YOU STILL HERE??? You must have absolutely no life! What a shame. I can still be optimistic and look at the longer-term picture while you and all of the others like you can just be so negative and hopeless and try to live off the fear of others. Kind of like terrorism-----wouldn't you say?

    Sentiment: Strong Buy

  • Reply to

    The no reason rally

    by oilup12345 Jun 16, 2016 2:54 PM
    mgm2020 mgm2020 Jun 16, 2016 3:05 PM Flag

    A much bigger question is WHY the stock dropped as low as it did after the positive trial results with many other coals in the fire? The answer is the market and manipulation. When the market and manipulators or ready for IDRA to pop back up------it will-----and it could do it in a hurry. It is WAY too low.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jun 16, 2016 2:14 PM Flag

    You have NEVER posted a single opinion on any stock, whether accurate or not which was based on any research or facts. You seem unable to form your own basis of thought, and I expect that to continue since all you do is re-act rather than post anything that could possibly be acted upon. And as for causing "damage", if anyone buys a stock or sells a stock based on anything read on a message board without doing their own due diligence, then they should not be investing in anything other than a mutual fund or a CD. Give us your take on your favorite stocks right now jk....

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jun 16, 2016 12:34 PM Flag

    Somebody once said, "all you need is love".

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jun 16, 2016 11:39 AM Flag

    Your post is worthless, just like you are-----and all of your aliases. Why you still hang around here when any downside is extremely limited and the upside potential is limitless is nonsensical.

    Sentiment: Strong Buy

  • show that a move back up to the upper band is likely. BUY ON THE DIPS-----and we are still in a DIP after reaching almost $7 twice in the last 3 months. Time for attempt number 3??

    Sentiment: Strong Buy

  • that is why the stock is holding up today. TROV has some of the strongest prospects and greatest potential of any small biotech company, and the fact that it is not relying on any developmental drugs which require years and years of testing and cumulative data before anything ever hits the market and has a possibility of generating revenue it a very strong PLUS. TROV has already conducted the studies in affiliation with the best cancer treatment facilities in the world and accumulated remarkably strong and convincing data showing that their urine based biopsy---TROVERA---and their PCM technology and science----it at least as reliable and accurate as blood test or invasive tissue biopsy, and due to the limits of both of those tests, even MORE sensitive than both in some cases. THIS IS HOW YOU CHANGE MEDICINE----and TROV is on the cusp of doing just that. And if they don't do that, then whoever BUYS THEM will!

    Sentiment: Strong Buy

  • and it can only be seen as a positive for the stock----especially on a day and with a market like this. IDRA, like so many other biotechs has been overly beaten down----and IDRA, unlike many others, is sitting on POSITIVE trial results in a condition and a patient population with few good options. The melanoma 2125 trial has now been proceeding for 6 months, and with a 17 week course of treatment there should definitely be preliminary information and data available to SOMEONE. And with the history of treating melanoma with Yervoy very well known, if there are positive results adding 2125 they would be apparent fairly quickly and they could be quite striking. But, in any case, over 200,000 shares in the span of 2 minutes with someone buying UP the price(and over a 15% increase) it's possible that IDRA may be ready to pull out of it's funk and start heading higher.

    Sentiment: Strong Buy

  • Reply to

    best day since early december

    by dopplerdaver Jun 16, 2016 11:04 AM
    mgm2020 mgm2020 Jun 16, 2016 11:08 AM Flag

    There are a few possibilities: Large size fund buy, large fund short-covering, buy triggers tripped(similar to sell-stops being taken out on the downside), positive data leak????, impending news, as yet unknown buyout rumor.

    Sentiment: Strong Buy

  • Reply to

    lol....

    by hardcider65 Jun 14, 2016 3:39 PM
    mgm2020 mgm2020 Jun 14, 2016 4:02 PM Flag

    And---on any given day we could wake up and see the headline, "ACAD agrees to be acquired by Pfizer(or any one of a handful of other companies) for a price of $75/share in cash." I am NOT attempting to play any games with a few thousand shares and risking doing that on the wrong day!

    Sentiment: Strong Buy

OCLR
4.75+0.16(+3.49%)Jun 28 4:00 PMEDT